NCT04310345

Brief Summary

This study will evaluate the effects of human-animal interaction on reducing anxiety, depression, worry, and pain and enhancing quality of life in children ages 6-17 years old with a life threatening cancer and their parent caregivers.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
74

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 13, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 17, 2020

Completed
1 year until next milestone

Study Start

First participant enrolled

March 31, 2021

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 9, 2024

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 27, 2024

Completed
2 months until next milestone

Results Posted

Study results publicly available

August 19, 2024

Completed
Last Updated

August 19, 2024

Status Verified

July 1, 2024

Enrollment Period

2.9 years

First QC Date

March 13, 2020

Results QC Date

June 27, 2024

Last Update Submit

July 24, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Pediatric Quality of Life

    The Pediatric Quality of Life Inventory (PedsQL) was administered to children and their parents (proxy for child quality of life) at baseline, week 4, and week 8 visits. Weeks 4 and 8 were after interacting with a therapy dog. Baseline surveys collected without seeing a therapy dog. The PedsQL Measurement is a validated scale to assess health-related quality of life in children and adolescents with acute and chronic health conditions. Scores are scaled from 1-100, with higher scores indicative of better quality of life.

    Up to 2 months

  • Anxiety

    The state-trait anxiety inventory State sub scale was administered to children (STAI-Child) and their parents (STAI) at baseline, week 4, and week 8. The 20-item STAI-CH is a validated scale for anxiety in children aged 5-17; the 20-item STAI is validated to assess anxiety in adult participants. The State subscale is intended to assess level of anxiety at the time of survey administration. Possible range of scores of the STAI-CH State subscale is 20-60, while the possible range from the STAI state subscale for adults is 20-80. Higher scores are indicative of increased anxiety. Baseline data were obtained without seeing a therapy dog, whereas STAI-CH and STAI surveys were conducted after seeing the therapy dog at weeks 4 and 8.

    Up to 2 months

Study Arms (1)

Animal-Assisted Interaction

EXPERIMENTAL

Children and their caregivers will spend approximately 10-15 minutes with a registered canine and its owner during potentially anxiety-producing visits to the clinic or hospital.

Behavioral: Animal-Assisted Interactions

Interventions

Child and caregivers will spend approximately 10-5 minutes with a registered canine and its owner during potentially anxiety-producing visits to the clinic or hospital.

Animal-Assisted Interaction

Eligibility Criteria

Age6 Years+
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Child:
  • Children age 6-17 years old that have been diagnosed with advanced cancer as defined by any stage of relapsed, recurrent or refractory cancer
  • Able to understand English or Spanish to complete consents and surveys
  • Parent or Guardian:
  • Parent or guardian as determined by person who brings child to \>50% of their clinic visits
  • Able to understand English or Spanish to complete consents and surveys

You may not qualify if:

  • Self-reported fear of or allergies to canines
  • Cognitive impairment as identified by healthcare team or inability to complete consenting process

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Monroe Carell Jr Children's Hospital at Vanderbilt

Nashville, Tennessee, 37232, United States

Location

MeSH Terms

Conditions

RecurrenceNeoplasms

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Dr. Mary Jo Gilmer
Organization
Vanderbilt School of Nursing

Study Officials

  • Maryjo Gilmer, PhD

    Vanderbilt Medical Center

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

March 13, 2020

First Posted

March 17, 2020

Study Start

March 31, 2021

Primary Completion

February 9, 2024

Study Completion

June 27, 2024

Last Updated

August 19, 2024

Results First Posted

August 19, 2024

Record last verified: 2024-07

Locations